Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Hill

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Genome Research|October 26, 2019
A chromosome-level assembly of the Atlantic herring genome-detection of a supergene and other signals of selectionMats E Pettersson, Christina M Rochus, Fan Han, et al.
Nature Medicine|March 17, 2026
First-line zolbetuximab plus mFOLFOX6 and nivolumab in unresectable CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: a phase 2 trialKohei Shitara, Hirokazu Shoji, Nicola Fazio, et al.
Science Advances|June 18, 2019
Unprecedented reorganization of holocentric chromosomes provides insights into the enigma of lepidopteran chromosome evolutionJason Hill, Pasi Rastas, Emily A Hornett, et al.
Nature|October 14, 2011
Solutions for a cultivated planetJonathan A Foley, Navin Ramankutty, Kate A Brauman, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 18, 2024
Equity and modeling in sustainability science: Examples and opportunities throughout the processAmanda Giang, Morgan R Edwards, Sarah M Fletcher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 19, 2019
A Somatostatin Receptor Subtype-3 (SST<sub>3</sub>) Peptide Agonist Shows Antitumor Effects in Experimental Models of Nonfunctioning Pituitary TumorsMari C Vázquez-Borrego, Vandana Gupta, Alejandro Ibáñez-Costa, et al.
Journal of Medicinal Chemistry|April 27, 2012
Discovery and optimization of a series of 3-(3-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amines: orally bioavailable, selective, and potent ATP-independent Akt inhibitorsMark A Ashwell, Jean-Marc Lapierre, Christopher Brassard, et al.
Agriculture and Human Values|August 25, 2020
The urgency of transforming the Midwestern U.S. landscape into more than corn and soybeanLinda S Prokopy, Benjamin M Gramig, Alisha Bower, et al.
Blood|January 8, 2025
Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD-mutated AMLMark J Levis, Mehdi Hamadani, Brent R Logan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2024
Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of <i>FLT3</i>Mark J Levis, Mehdi Hamadani, Brent Logan, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Genome Research|October 26, 2019
A chromosome-level assembly of the Atlantic herring genome-detection of a supergene and other signals of selectionMats E Pettersson, Christina M Rochus, Fan Han, et al.
Nature Medicine|March 17, 2026
First-line zolbetuximab plus mFOLFOX6 and nivolumab in unresectable CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: a phase 2 trialKohei Shitara, Hirokazu Shoji, Nicola Fazio, et al.
Science Advances|June 18, 2019
Unprecedented reorganization of holocentric chromosomes provides insights into the enigma of lepidopteran chromosome evolutionJason Hill, Pasi Rastas, Emily A Hornett, et al.
Nature|October 14, 2011
Solutions for a cultivated planetJonathan A Foley, Navin Ramankutty, Kate A Brauman, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 18, 2024
Equity and modeling in sustainability science: Examples and opportunities throughout the processAmanda Giang, Morgan R Edwards, Sarah M Fletcher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 19, 2019
A Somatostatin Receptor Subtype-3 (SST<sub>3</sub>) Peptide Agonist Shows Antitumor Effects in Experimental Models of Nonfunctioning Pituitary TumorsMari C Vázquez-Borrego, Vandana Gupta, Alejandro Ibáñez-Costa, et al.
Journal of Medicinal Chemistry|April 27, 2012
Discovery and optimization of a series of 3-(3-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amines: orally bioavailable, selective, and potent ATP-independent Akt inhibitorsMark A Ashwell, Jean-Marc Lapierre, Christopher Brassard, et al.
Agriculture and Human Values|August 25, 2020
The urgency of transforming the Midwestern U.S. landscape into more than corn and soybeanLinda S Prokopy, Benjamin M Gramig, Alisha Bower, et al.
Blood|January 8, 2025
Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD-mutated AMLMark J Levis, Mehdi Hamadani, Brent R Logan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2024
Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of <i>FLT3</i>Mark J Levis, Mehdi Hamadani, Brent Logan, et al.
Pageof 7